Compare TLPH & SDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | SDEV |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.5M | 65.3M |
| IPO Year | 2010 | 2007 |
| Metric | TLPH | SDEV |
|---|---|---|
| Price | $0.87 | $0.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.13 | N/A |
| AVG Volume (30 Days) | 77.5K | ★ 11.4M |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $2,151,000.00 | $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.69 | $0.76 |
| 52 Week High | $1.57 | $9.82 |
| Indicator | TLPH | SDEV |
|---|---|---|
| Relative Strength Index (RSI) | 27.98 | 38.44 |
| Support Level | $0.74 | N/A |
| Resistance Level | $0.89 | $1.28 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 25.63 | 6.01 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.